52
Participants
Start Date
July 24, 2018
Primary Completion Date
February 13, 2023
Study Completion Date
February 13, 2023
Panobinostat
"Panobinostat should be taken orally once on each scheduled day at about the same time, either with or without food. Each dose of panobinostat should be taken with a cup of water.~The capsules should be swallowed as whole. If vomiting occurs during the course of treatment, no re-dosing is allowed before the next scheduled dose. If one dose is forgotten during the morning on a scheduled treatment day then the missed dose should be taken on that same day within 12 hours. After more than 12 hours, that day's dose should be withheld, and the patient should wait to take panobinostat until the next schedule treatment day. The patient should then continue treatment with the original dosing schedule.~Panobinostat will be administered at a dose of 20 mg three times weekly (TIW) every second week and will be dosed on a flat scale of mg/day and not by weight or body surface area.~Panobinostat will be dispensed as a 20 mg capsule or as two 10 mg capsules."
Erasmus University Medical Center, Rotterdam
Otto-von-Guericke University, Magdeburg
Robert Bosch Krankenhaus, Stuttgart
Klinikum Nürnberg Nord, Nuremberg
University Hospital Jena, Jena
Universitätsklinikum Leipzig, Leipzig
Klinikum Augsburg, Augsburg
University Hospital Bonn, Bonn
University Hospital Frankfurt, Frankfurt
University Hospital Hamburg-Eppendorf, Hamburg
Universitätsmedizin Mainz, Mainz
Klinikum Mannheim, Mannheim
Philipps-Universität Marburg, Marburg
University Hospital Münster, Münster
Maastricht University Medical Center, Maastricht
Universtity Hospital Dresden, Dresden
Amsterdam University Medical Center - VUMC, Amsterdam
University Medical Center Groningen, Groningen
Radboud UMC, Nijmegen
Lead Sponsor
Stichting Hemato-Oncologie voor Volwassenen Nederland
OTHER
Polish Adult Leukemia Group
OTHER
Schweizerische Arbeitsgemeinschaft für klinische Krebsforschung
UNKNOWN
Goethe University
OTHER